NIA Interventions Testing Program: Investigating Putative Aging Intervention Agents in a Genetically Heterogeneous Mouse Model
暂无分享,去创建一个
Randy Strong | Nancy L. Nadon | R. Strong | N. Nadon | Richard A. Miller | D. Harrison | David E. Harrison
[1] Z. D. Sharp,et al. Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction , 2014, Aging cell.
[2] R. A. Miller,et al. Design of aging intervention studies: the NIA interventions testing program , 2008, AGE.
[3] Marco Pahor,et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice , 2009, Nature.
[4] Dudley Lamming,et al. Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α‐glucosidase inhibitor or a Nrf2‐inducer , 2016, Aging cell.
[5] B. Ames,et al. Acarbose, 17-α-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males , 2013, Aging cell.
[6] R. de Cabo,et al. Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium-chain triglyceride oil on life span of genetically heterogeneous mice. , 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.
[7] R. de Cabo,et al. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. , 2011, The journals of gerontology. Series A, Biological sciences and medical sciences.
[8] Kenneth L. Hensley,et al. Nordihydroguaiaretic acid and aspirin increase lifespan of genetically heterogeneous male mice , 2008, Aging cell.
[9] K. Flurkey,et al. Life extension by diet restriction and N-acetyl-L-cysteine in genetically heterogeneous mice. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.